Key facts
- This page summarizes Jeffrey Thomas Perez's Form 4 filing for PRECIGEN, INC. (PGEN).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 31 May 2024, 19:04.
Jeffrey Thomas Perez - 31 May 2024 Form 4 Insider Report for PRECIGEN, INC. (PGEN)
- Reporting relationship
- SVP, IP Affairs
- Issuer ticker
- PGEN
- Reported as of
- 31 May 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 31 May 2024, 19:04:55 UTC
- Prior SEC filing
- 03 May 2024
- Next SEC filing
- 13 Aug 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jeffrey T. Perez, by Donald P. Lehr, as attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jeffrey Thomas Perez filed Form 4 for PRECIGEN, INC. (PGEN) on 31 May 2024.
Change
- Previous filing in this sequence was filed on 03 May 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PGEN
transaction
Derivative
Option to Purchase Common Stock (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +300,000
- Change %
- Price
- $0.000000
- Shares after
- 300,000
- Date
- 31 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 300,000
- Exercise price
- $1.40
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The options vest 25% on May 31, 2025 and in equal monthly installments for three years thereafter.